Showing posts with label diplomacy. Show all posts
Showing posts with label diplomacy. Show all posts

[News]Vaccine diplomacy is the vane of structural competition between China and the United States



1. The direction of Sino-US structural competition remains unchanged
The new crown epidemic accelerated the deterioration of US-China relations at the end of Trump's term. It not only obliterated the temporary easing of the first phase of the trade agreement in early 2020, but also extended the hostility between the two sides to the entire government and society. It even launched a full-scale confrontation in science and technology, education, finance, and ideology, which made all the geopolitical hot spots surrounding the rising China even more tense. Except that the Sino-US and global trade links are more dense than those of the Cold War and earlier, and it is difficult to "decoupling" immediately, in all other respects, the confrontation between the great powers is even worse than the confrontation between Britain and Germany on the eve of 1914.
Although Trump lost the election and Biden accurately chose to talk to Xi Jinping during the Lunar New Year after taking office, the Biden team then, as indicated before the election, fully launched the "America is back." The seven major industrialized countries (G7), the Four-Party Security Dialogue (QUAD), and the upcoming "Summit for Democracy" (Summit for Democracy) will regroup from the aforementioned "full-field" and various aspects to deal with the "Chinese challenge." Obviously, the conspiracy theorists who promoted "China Biden" were completely wrong. As Secretary of State Antony Blinken said, the direction of the Trump team to check and balance China is no problem in terms of US interests. The problem lies in the wrong "method" of Trump, Mike Pompeo and others in competing with China.
2. Global anti-epidemic cooperation is inadequate, and rich countries accumulate criticism
The epidemic is the short-term highlight of this competition. From the perspective of "human security," China and the United States ostensibly agree that, just like climate change and emission reduction, joint epidemic prevention should be an area that transcends national borders and some of the two powers should cooperate. And I believe that these topics not only took up some time during the two-hour call on Xi’s, but also a few topics where both sides can treat each other friendly. However, up to now, the two sides have not seen any follow-up communication and promotion at work levels in relevant fields. Instead, people have seen that the two major camps of China and the United States continue to compete with each other and strive for support in relevant international forums.
Although the Chinese medicine Coxing CoronaVac vaccine launched earlier and the national medicine BBIBP-Corv vaccine launched later are traditional inactivated vaccines, they have been administered more quickly and more in developing countries in Asia, Africa and Latin America. The health authorities of some countries have not only Officially approved for listing, leaders of Turkey, Indonesia, Chile, and Peru also publicly vaccinated. While the European Union complained that it was unable to purchase the Oxford vaccine produced by the Brexit Britain, Chinese vaccines entered Eastern Europe's Hungary and Serbia. Xi Jinping also proposed cooperation with Eastern European vaccines at the China-Eastern Europe 17+1 summit. Although the total dose of foreign aid is not yet known, Beijing officials pointed out that it has provided "vaccine assistance" to 53 developing countries and "exported vaccines" to 22 countries.
3. China's proposal of "Priority to Developing Countries" creates propaganda pressure on the West
The Secretary-General of the United Nations and the Director-General of WHO have repeatedly complained about the uneven distribution of global vaccines, which will delay the time limit for the world to get rid of the epidemic. Countries such as the United States and the United Kingdom have sufficient R&D technologies and resources, and rapid vaccination actions. Foreign media quoted Western NGOs as saying that the number of doses scheduled and stockpiled in the United States, the European Union, the United Kingdom, Australia, Canada, and Japan has far exceeded the need for 1 billion doses. However, its European allies and Canada suffer from the dilemma of "ordering but not getting the goods." Except for the two small and wealthy foreign countries with the highest vaccination rate in the world, Israel and the UAE, the major powers are led by the United States and Britain. In NATO, there is a peculiar phenomenon that Turkey leads Germany and France. With a population of less than 40 million, Canada has ordered 400 million doses of vaccines, but the supply is short. For example, the Russian "satellite" vaccine came out earlier and was used in Argentina, Venezuela and other countries, and was approved by India to co-produce it. However, the United States and Ukraine have banned its use and sanctioned Russian institutions participating in research. The chaos in anti-epidemic cooperation within the Western bloc and the resistance to China and Russia bluntly prove the important role of "national priority" and "bio-power" in geopolitical confrontation.
When attending the Security Council Ministerial Meeting on Vaccine Issues on the 19th, Chinese Foreign Minister Wang Yi pointed out that the essence of the vaccine deficit is "capacity deficit" and "distribution deficit", and requested the implementation of the WHO-led anti-epidemic and "vaccine program" (COVAX) It should implement the "developing country first" principle, and earlier claimed that it would provide COVAX with 10 million doses to "urgently needed developing countries." In May last year, the United States, Australia and other countries proposed to "independently send an investigation team" to investigate the epidemic in China at the World Health Assembly. The proposal was amended to be an inspection "under the leadership of the WHO." After the visit of the delegation in February this year ended the field investigation in Wuhan, the members of the expert group ruled out the possibility of the virus from the Wuhan virus. They also pointed out that the epidemic may appear in other parts of China in October 2019 or earlier, reducing the pressure on China issues; plus Beijing has targeted the principle of giving priority to developing countries, which is believed to have exerted tremendous pressure on the US, Britain and Western groups.
4. The U.S., Britain and G7 make urgent moves, hoping to win back the moral high ground
When Biden participated in the election, he promised that the United States must return to non-traditional security multilateral mechanisms such as the World Health Organization and the Climate Change Convention. This is an effective way to respond to China's challenges. When Brinken attended the Security Council vaccine ministerial meeting, he also promised to allocate 200 million US dollars to the WHO. If it can be fulfilled, it will be able to make up the 80 million US dollars arrears by Washington. The G7 summit held at the same time also issued a statement saying that "including the acquisition of the New Coronary Pneumonia Tool Acceleration Program (ACT-A) and COVAX's US$4 billion in financial assistance, the G7 will provide assistance to reach US$7.5 billion." It has always been concerned about Africa. French President Emmanuel Macron called on the United States and Europe to give 5% of its production to developing countries. This was responded by German Chancellor Angela Merkel. The United Kingdom, which is the leader in vaccination, also promised to give priority to the remaining vaccines. What remains is that the pragmatic approach is quite different from China's "feat" of assisting Tanzania to build a railway during the Cultural Revolution. (According to statistics, the United States has administered more than 40 million doses of vaccines, the United Kingdom, with a population of more than 60 million, has also administered 17 million doses, and Canada, with a population of 35 million, is still less than 1 million doses, with a population of 1.4 billion. China has administered approximately 22 million doses.)
In fact, Western Groups are still far ahead of China in terms of technology and resources. The reason for being passive on the issue of the epidemic is that apart from the fact that the regime system is different from that of mainland China, it must give priority to meeting the expectations of the people of the country under the pressure of public opinion. What is more important is that the "new right" created by the economic problems of various countries in recent years has used populist The agitation inspires the principle of “domestic supremacy”, which not only greatly limits the strategic space for progressives to promote “globalism”, but also gives Beijing an opportunity to alleviate the incomprehension of the “third world” on the outbreak of the epidemic on the mainland, and the rejuvenation of China. Worry.
If Washington and London are only committed to consolidating their surveillance programs on China in India, they ignore that India can still conduct naval exercises with Russia and Iran; or block the Chinese media mouthpiece, but fail to pay attention to the historical perspective and think that Universal has the problem of double standards; or strengthening the joint operation of the "four-party dialogue", but underestimating the autonomous needs of the ASEAN, South Korea, and the island countries of Oceania. To ensure structural competition with China, we will have to experience a long and full of crisis. process.

In line with expectations = good market. Market analysis on September 24

The Fed overnight was a bunch of nonsense, almost nothing useful. Interest rates continue to remain unchanged at 0-0.25%. As a whole, we sti...